Ethical considerations in industry-sponsored Multiregional clinical trials.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 230, doi. 10.1002/pst.458
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2010 AND VI 9 AND IP 3
Results: 9
1
2
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials - Asian perspective.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 201, doi. 10.1002/pst.442
- By:
- Publication type:
- Article
3
Multi-regional clinical trials - What are the challenges?
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 171, doi. 10.1002/pst.457
- By:
- Publication type:
- Article
4
Trial design issues and treatment effect modeling in multi-regional schizophrenia trials.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 217, doi. 10.1002/pst.439
- By:
- Publication type:
- Article
5
An optimal adaptive design to address local regulations in global clinical trials.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 179, doi. 10.1002/pst.456
- By:
- Publication type:
- Article
6
Consideration of regional difference in design and analysis of multi-regional trials.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 173, doi. 10.1002/pst.440
- By:
- Publication type:
- Article
7
Sample size and proportion of Japanese patients in multi-regional trials.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 207, doi. 10.1002/pst.455
- By:
- Publication type:
- Article
8
Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspective.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 190, doi. 10.1002/pst.448
- By:
- Publication type:
- Article
9
Assessing consistent treatment effect in a multi-regional clinical trial: a systematic review.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 3, p. 242, doi. 10.1002/pst.438
- By:
- Publication type:
- Article